Navigating the M&A Landscape in Cell and Gene Therapy: What Manufacturers Need to Know
December 4, 2025
By MasterControl
The CGT M&A landscape is booming, but manufacturing readiness is now key to valuation. Discover why digital maturity, robust CGT manufacturing, and advanced cell therapy software, including MES for cell and gene therapy, are critical for attracting acquirers. Uncover the challenges and competitive advantages in this blog post – your essential guide to maximizing M&A appeal.
Full story